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1. Introduction  
Bioinformatics can be thought of as a special case of important innovation as it comes at the 
intersection of different General-Purpose Technologies (GPTs) (Foray et al., 2009) mainly 
generated in the two domains of biological sciences and information and communications 
technology (ICT) (Majumdar et al., 2009; Lewis et al., 2016). These two domains keep on 
feeding each other. On one side, ICT, such as computers, networks and robotics, are 
nowadays playing a central role in transforming the practices of biology (Chicurel, 2002; 
Pop and Salzberg, 2008); indeed, these advancements are changing what biologists do, how 
they work, the way they carry out experiments, the universe of objects they deal with, and 
the kind of knowledge they can generate. They also have reoriented biology towards large-
scale investigations through advanced statistical methods and big data. This change marks a 
break with older kinds of biological work that mainly aimed at identifying and characterizing 
single and specific entities.  
On the other side, having seen new horizons in their research, biologists are increasingly 
accumulating data from multiple sources (Cook et al., 2015). Therefore, a key challenge for 
Bioinformatics technologies becomes the creation and maintenance of sophisticated tools 
and techniques for the storage, analysis, and mapping of this biological information. 
Therefore, it is reasonable to conceive the emergence and development of this peculiar type 
of GPT at the crossroads of science and technology. Such an intersection is made even 
clearer by referring to the only work (Hallam, 2013) that combines historical developments 
and ethnographic perspectives on Bioinformatics. Herein, the author depicts a complex 
relationship between science and technology that contributed - and still shape – the 
Bioinformatics industry.  
However, an important gap remains in the current state of the art: large-scale investigations 
on the antecedents of the patenting activity in Bioinformatics are almost silent. Pioneering 
contributions (e.g., Park, 2012; Rasmussen, 2010; Patel, 2003; Saviotti et al., 2000) provide 
a valuable but still limited view of both the emergence and evolution of the industry, not 
shedding light on its scientific and technological knowledge recombination and diversity. 
Therefore, this research focuses on exploring the interplay of scientific and technological 
diversity in the emergence and developments of the Bioinformatics industry. Precisely, we 
draw upon GPT and knowledge recombination theory to get insights on whether – and to 
what extent – scientific and technological diversity contribute to increase the odds for a 
Bioinformatics invention to have impact and become a platform for other technological 
developments.  
This paper makes a theoretical contribution towards understanding knowledge 
recombination mechanisms and antecedents for GPTs, accounting for the fact that their 
influence on the generation of impactful inventions is nuanced. Indeed, empirical support 
reveals that different degrees of impact require different degrees of knowledge diversity. At 
the same time - and importantly for both practitioners and scholars - recombining diverse 
scientific and technological knowledge bases not always lead to impactful inventions. Our 
study may be the first revealing that for GPTs to increase their scope, inventors have to 
wisely recombine scientific and technological prior art. It is also one of the few studies 
shedding light on the relationship between diversity and recombination of the antecedents 
and impact of a special case of GPT. 
The remaining of the paper unfolds as follows: the next section discusses relevant theory 
and motivates the choice of diversity indicators. Then, a discussion about research setting is 
provided, followed by a methodological section. Finally, results and implications conclude 
the article. 
2. Theoretical background and research questions 
Since the seminal article on GPTs (Bresnahan and Trajtenberg, 1995), this concept is gaining 
momentum as it has further evolved (Carlaw and Lipsey, 2011; Bresnahan, 2010; David and 
Wright, 2006) being applied in knowledge domains such as economic history (e.g., Crafts, 
2003), industrial organization (e.g., Lindmark, 2005), economic policy (e.g., van Zon and 
Korenenberg, 2007), innovation studies (e.g., Andergassen et al., 2017), and translated into 
several models (e.g., Schultz and Joutz, 2010; Helpman, 1998). What all these approaches 
substantially share is the following key point: GPTs stand on technological solutions which, 
thanks to their high level of technological generality (Gambardella and Giarratana, 2013), 
may find applications in different markets and knowledge domains (Ardito et al., 2016). 
They are often considered as impactful innovations that pave the way to a swarm of 
incremental innovations transversally impacting several industries (Feldman and Yoon, 
2012; Coccia, 2016). They are the engine of the economic (endogenous) growth (Ardito et 
al., 2016; Schaefer et al., 2014) and increased productivity in several contexts (Feldman and 
Yoon, 2012). Overall, GPTs give birth to technological discontinuities which, for their 
inherent general scope, bring with them a broad array of applications.  
A definition which gathers together these perspectives is provided by Lipsey and co-authors 
(2005, p. 96): a GPT “is a single technology, recognizable as such over its whole lifetime 
that initially has much scope for improvement and eventually comes to be widely used, to 
have many uses, and to have many spillover effects.” Still Lipsey and co-authors (2005) 
distinguish between five classes of GPTs namely, materials, ICT, power sources, 
transportation equipment, and organizational forms.  
But Bioinformatics escapes univocal identifications: it does not seem to fit exactly in one of 
the five classes only and this is why it is identified as a special case of GPT (Foray et al., 
2009). To give the reader an idea of the wide spectrum Bioinformatics opens, it suffices to 
consider some examples of the ways it aids the experimental approaches: first, for bridging 
proteins, DNA, and RNA sequences, a number of databases have been built (e.g., NCBI’s 
SNP database1, ERGO 2.0 genome browser2) for which BLAST3 (Basic Local Alignment 
Search Tool) can be used; second, for searching for functional patterns in proteins and 
nucleic acids, the ExPASy4 (Expert Protein Analysis Model), or the ENSEMBL5 tool; 
finally, GPCRDB6 is usually used for determining if there are known interactions among 
proteins. Bioinformatics technologies, applications, and solutions touch the following fields: 
microbial genome applications, molecular medicine, personalized medicine, preventative 
medicine gene therapy, drug development, biotechnology, climate change studies, insect 
resistance, vetinary science, evolutionary studies. 
Notwithstanding its revolutionary role, and although the existence of a rich theoretical 
literature on GPTs (Feldman and Yoon, 2012), sound empirical investigations on the 
antecedents of GPTs are scant (Thoma, 2009; Lo and Sutthiphisal, 2010). As recent literature 
advocates, inventions of such a kind may require a broad search for information and the 
recombination of different knowledge bases (Kaplan and Vakili, 2014). Recombination 
mechanisms are increasingly being associated with the accomplishment of impactful 
inventions (Fleming and Sorenson, 2004; Schilling and Green, 2011; Carnabuci and Operti, 
2013): in fact, recent research shows it is going through a variety of cognitive-search 
processes (Acar and Van den Ende, 2016) that atypical (Uzzi et al., 2013) or unconventional 
combinations (Simonton, 1999) make concrete. The fact that there is a link between 
                                                     
1 https://www.ncbi.nlm.nih.gov/SNP/  
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recombination of diverse knowledge bases and impact is increasingly recognized and 
empirical studies start to find systematic evidence on it (Keijl et al., 2016). Developing 
technologies drawing on diverse knowledge areas contribute to the creation of GPTs, since 
this enhances inventions’ technological generality. Accordingly, we take the view of 
inventions as the outcome of a recombination process over technology and scientific 
landscapes (Fleming and Sorenson, 2001; Savino et al., 2015, Nakamura et al., 2015). This 
recombination of diverse knowledge bases, if not their interplay, may play an important role 
in spanning the boundaries of GPTs (Novelli, 2015). According to Petsas (2003), the inputs 
of GPTs are basically complementary and it makes relevant looking at whether – and to what 
extent – diversity is at the basis of the impact of the Bioinformatics industry.  
To this purpose, we will have a deep look at the patents’ prior art (Trajtenberg et al., 1997; 
Chen and Hicks, 2004; Callaert et al., 2006) as they reflect the recombined knowledge at the 
basis of inventions in the field of investigation. Prior art in patents can be distinguished in 
patent references - PRs, representing the cited technological contributions - and non-patent 
references - NPRs, representing the cited scientific contributions. Analyzing their inherent 
diversity may provide us with the opportunity to systematically examine the relationships 
between scientific and technological contributions at the basis of key inventions in the 
Bioinformatics industry. 
Former contributions (Park, 2012; Rasmussen, 2010; Patel, 2003) focus on patents in 
Bioinformatics and provide valuable insights when it comes to consider the identification of 
the main technological classes and subclasses. However, they have two main limitations: 
first, they do not focus on the characteristics of prior art; second, they do not provide 
systematic evidence of the link between diversity in the prior art and GPT impact. Following 
our theorizing, two main research questions emerge: 
What is the link between knowledge recombination and the impact of Bioinformatics 
inventions? And, to what extent does diversity of scientific and technological knowledge 
bases matter? 
3. Characteristics of Bioinformatics 
3.1 Early days and growth of the industry  
The history of Bioinformatics traces back to the late 1970s when Staden, in a series of studies 
published on Nucleic Acids Research (seminal paper published in 1977), outlined the basics 
for the development of computer programs allowing researchers to analyze DNA sequences. 
However, they could be used on large mainframe computers and run with non-standard 
programming languages; these two characteristics made adapting them to small (48K) 
microcomputers tile consuming and not even economically affordable. These reasons, along 
with the need to facilitate dissemination, inspired the work of James M. Pustell (then Ostell) 
at the Kafatos Laboratory in Harvard’s Department of Cellular and Development Biology. 
He worked on – and improved – four aspects: interaction, data management, data analysis, 
and software compatibility (Pustell and Kafatos, 1982). It was a success (Hallam, 2013) and 
since its inception, the Bioinformatics industry underwent periods of technological and 
scientific challenges, feeding each other over a long period of time (Ouzonis and Valencia, 
2003).  
What follows is an overview of the challenges addressed by technological advancements. In 
the 1990s the most urgent challenge was to deploy systems able to collect huge amounts of 
data (Mushegian, 2011). At that time, the technical advancements were as such that tools 
like the Genome Sequence Database allowed scientists to process data within 13 hours; a 
performance that only few years before was of 13 months (Robbins, 1996). Since the 
beginning of the Human Genome Project in 1990, always more sequence data entered the 
databases (Robbins, 1996).  
Then, a new challenge showed up: data integration. As Robbins (1996, p. 468) puts it: 
“sequence data had to be linked to map data; protein structures, connected to metabolic 
function; species data, connected with ecosystem data.” Although progress has been made, 
still today this challenge is considered as perennial issue in that the increase in the quantity 
of data brings complexity (Goble and Stevens, 2008). Different approaches to data 
integration are nowadays available ranging from service-oriented architectures, data 
warehousing, view integration; workflows, mashups, and semantic web (Goble and Stevens, 
2008). 
Another set of challenges laid in the problem of data standardization and data indexing 
(Robbins, 1996). Recent technological advancements allow for solutions which can also 
allow standardizing and indexing big data, mainly based on supervised and unsupervised 
machine learning techniques (Greene et al., 2014).  
In terms of scientific developments, it is worth considering that it is only from the mid-1990s 
onward that new journals, new conferences, and new training programs (and textbooks) 
began to appear supporting this new domain of knowledge (Hallam, 2013): in 1994, the first 
statement on the birth of computational biology as a discipline in its own right was made by 
the new Journal of Computational Biology (Davison, 1994); in 1995, the first Bioinformatics 
textbook was published Waterman (1995); in 1998, the journal Computer Applications in 
the Biosciences (established in 1985) changed its name to Bioinformatics (Hallam, 2013) 
highlighting “the importance of Bioinformatics, a subject which is emerging as one of the 
leading scientific disciplines for the next century” (CABIOS, 1997).  
Afterwards, the need for Bioinformatics specialized curricula emerged (Altman, 1998). 
Under the headline ‘Bioinformatics: Jobs Galore’, Science Careers reports in 2000 that 
“everyone is struggling to find people with the Bioinformatics skills they need” (Taylor, 
2000). Public entities in general and particularly universities, started to pay attention to the 
rise of this new discipline (Black and Stephan, 2004). In the period 1997-2004, the number 
of Bioinformatics programs within universities more than tripled, twelve professional 
science Master’s in Bioinformatics were created, the number of Doctoral programs more 
than doubled, whereas the number of Bachelor’s programs tripled. 
Scientific projects like the Human Genome Project (HGP) strongly contributed to 
institutionalize Bioinformatics (Hallam, 2013). By the time the HGP came on the scene, 
independent initiatives spurred the growth of new institutional spaces for data work. What 
the Congress reasoned about the creation of the National Center for Biotechnology 
Information (NCBI) (Cook-Deegan, 1994) was that “knowledge in the field of biotechnology 
is accumulating faster than it can be reasonably assimilated” and that advances in 
computation were the solution (Smith, 2008). Specifically, the Congress emphasized the 
need of a distinct institutional home to deal with the different skills needed to design, 
development, implement, and manage biological information (Hallam, 2013). For the same 
reasons, in Europe, the European Bioinformatics Institute (EBI) was established as a quasi-
independent outstation of the European Molecular Biology Laboratory (EMBL). The 
acceleration and rapid completion of the HGP made it clear that, as one Nature editor put it, 
“like it or not, big biology is here to stay” (Editorial Nature, 2001, p. 545). Bioinformatics 
and HGP fed each other by enabling the production and synthesis of more and more data. 
2.2 Bioinformatics market and patents 
Already in 2000, the combination of segments characterizing Bioinformatics exceeded an 
estimated $700 million, making Bioinformatics one of the fastest growing areas of all life 
science related markets (SDI, 2001). Recent analyses confirm this picture: the global 
Bioinformatics market has been valued at $3.5 billion in 2013 and it is poised to reach $12.5 
billion by 2020 at a Compound Annual Growth Rate (CAGR) of 19.49% (Research and 
Markets, 2015). These numbers are probably underestimating the fact that certain 
pharmaceutical and biotechnology firms have extensive in-house Bioinformatics expertise, 
which never offers its services for sale (Saviotti et al., 2000). In any case - and consequently 
- the most active companies understood the impressive economic potential of this industry 
and started aggressively seeking patent protection for their Bioinformatics inventions with 
some attempting to corner the market (Vorndran and Florence, 2002; D’Souza, 2004; 
Rasmussen, 2010).  
However, patenting in Bioinformatics is complex as it deals with many dimensions such as 
lines of code, algorithms, data content, structures and user interfaces (Rasmussen, 2010). 
Despite some unique legal problems of this discipline (Ostler and Gollin, 2015; Welch, 
2002) and the persisting differences among the legal systems (McCubbin, 2003), patents are 
of greatest assistance in protecting most forms of intellectual property associated with 
Bioinformatics (Harrison, 2003). Figure 1 shows the evolution of the patenting activity in 
the Bioinformatics industry and relates it to the scientific and institutional milestones 
introduced in the former section.  
FIGURE 1 HERE 
Figure 1. Number of patents over the years and milestones 
 
As we will show in the next section, what further complicates the picture is that by entailing 
Bioinformatics a combination of GPTs, inventors potentially may come from different 
domains, relying then on diverse knowledge bases (Hallam, 2013). 
3. Methodology and data set 
3.1 Collecting Bioinformatics patents 
As there is no single and unique classification for Bioinformatics patents, a series of steps 
have been undertaken to carry out preliminary patent-based analyses by relying on the 
United States Patent and Trademark Office (USPTO)7 information. This allowed us to 
expand results stemming from former studies (Park, 2012; Rasmussen, 2010; Patel, 2003). 
The following data search and collection routine has been implemented: 
                                                     
7 http://www.uspto.gov/  
− First large-scale extraction of patents belonging to USPTO sub-classes identified in 
Park (2012) which in turn are based on Rasmussen (2010) and Patel (2003). First 
dataset generated. 
− Multiple keywords search based on Hallam (2013) (e.g., ‘Bioinformatics’, 
‘computational biology’, ‘genomics’, ‘data-based biological knowledge’) relying on 
patent title, abstract, and claims of patents to include only those which satisfied both 
the biotechnology and information technology content of Bioinformatics. Second 
dataset generated. 
− Merging of the two samples coming from the two former points. 
− Semi-automatic review and refinement of selected patents (including patent 
description), to ensure consistency. 
This routine resulted in a database of 14,754 Bioinformatics patents in the 1976-2014-time 
window. It is worthy to notice that 12% of the patents come from individual assignees 
(Appendix 1). From the distribution of the NAICS codes, we can also observe that the 
remaining assignees come from diverse industries and this confirms the fact that 
Bioinformatics is increasingly becoming an attractive field for heterogeneous actors. 
Universities are playing an important role too.   
3.2 Extracting prior art information 
Of all the Bioinformatics patents, we collected both cited non-patent references (NPRs) and 
patent references (PRs). Some problematic issues may exist in referring to patent citations 
as a way to identify knowledge linkage and recombination (Chen, 2007): the first disputation 
entails the difference between patent citations added by the applicant and examiners (e.g., 
Alcacer et al., 2009); second, some scholars point out that only NPRs self-cited by the 
inventors should be used as a way to trace the link between science and technology, as the 
ones from examiners and non-self-citations by the inventor introduce noise (e.g., Li et al., 
2014). Despite these controversial issues, by using patent citations (both NPRs and PRs), 
scholars have revealed knowledge diffusion and transfer (e.g., Nelson, 2009), trajectories 
and paradigms (Érdi et al., 2013); all in all, they provided with a more systematic 
conceptualization of innovation dynamics and related policies by building more accurate 
citations-based indicators (e.g., Callaert et al., 2006; 2012). We then follow Chen (2017) 
who argues it is reasonable to assume that patent citations are linked to knowledge. 
Several stages of data cleaning and harmonizing followed in order to extract the essential 
information allowing us to calculate indicators. A database has been built in which the 
following information showed up: patent ID; filing date; NPRs string; PRs string. This 
routine resulted in a database of 397,746 NPRs in the 1974-2013-time window and 194,288 
PRs in the 1972-2013-time window.  
Concerning the NPRs, the sources have been extracted from the entire string by creating 
specific macros in VBA Project. Appendix 2 provides the reader with an overview of the 
main NPRs. No one of the Bioinformatics journals show up in the top 1%, the reason is 
twofold: first, the Bioinformatics field is still in development and relatively recent journals 
need time to become relevant; second, it is an obvious consequence of the interdisciplinary 
nature of the field. Appendix 3 reports the main Bioinformatics journals and their 
frequencies, accounting for a 1.5% of the NPRs. 
Also, the sources needed to be classified as Science (SCI-covered) or Not Science (Not SCI-
covered) by following Callaert and co-authors (2006). To do that, we matched data in the 
Journal Citation Report’s database8. The matching was made on the basis of Journal title, 
and impact factor. We uniquely allocated 365,885 (91.98%) NPRs9 (see Table 1).  
 
TABLE 1 HERE 
Table 1. NPRs classification 
 
                                                     
8http://thomsonreuters.com/en/products-services/scholarly-scientific-research/research-management-and-
evaluation/journal-citation-reports.html  
9 Complete list available upon request. 
These values indicate that the sources that scientific journals are the main source to the 
development of Bioinformatics innovations are mostly. Figure 2 shows their distribution 
over the years. 
FIGURE 2 HERE 
Figure 2. Number of NPRs (green), Non-Journal (blue), SCI-covered (purple) and Not SCI-covered (red) 
references over the years (log scale) 
 
A relevant percentage of non-scientific items is present thus signaling that books, manuals, 
patent related documents, database entries, magazines (to mention just the main categories) 
have contributed to provide the necessary knowledge to bring the innovations into this 
sector. This is a first symptom of the necessary diversity of sources at the basis of the 
Bioinformatics inventions. 
Concerning the PRs, we extracted the technological sub-classes (2 and 3 digits) by following 
the IPC classification10. Table 2 shows the main technological sub-classes cited into 
Bionformatics patents11. This preliminary information confirms the interdisciplinary nature 
that lays at the basis of the growth and development of the Bioinformatics industry.  
TABLE 2 HERE 
Table 2. PRs classification 
3.3 Indicators 
A diversity index was selected to account for quantity and quality of both science (NPRs) 
and technology (PRs) in patents. Starting from a general measure of information content 
called Renyi entropy Ri of order α, we got the value of interest for this study which is the 
limit of the equation (Hill, 1973; Pielou, 1975) when α approaches 1. This yields to: 
H’ = Ri = - Σi 𝑝𝑖ln𝑝𝑖 
                                                     
10 http://www.wipo.int/classifications/ipc/en/  
11 Complete list available upon request.  
where pi is the proportion of individuals found in the i-th species. This is the well-known 
Shannon-Wiener measure of species diversity (H’), which is widely used in a number of 
different areas (Stirling, 1998; McDonald and Dimmick, 2003; Margaleff, 1972). The 
Shannon-Wiener diversity index H’ is used to calculate the NPRs and PRs diversity. 
In order to assess the odds for a Bioinformatics invention to have impact, the number of 
Forward Citations (FCs) is used as a proxy. Indeed, the number of FCs can be thought of as 
signalling the importance of a certain technology (Albert et al., 1991; Carpenter et al., 1993; 
Jaffe et al., 2000), especially in the case of GPTs (Youtie et al., 2007). The extent to which 
a GPT is cited and adopted for the development of future inventions gives an indication of 
their importance and usefulness (Keijl et al., 2016). A number of studies also support the 
evidence that FCs are a good indicator of both the social (Trajtenberg, 1990; Sapsalis et al., 
2006) and private value (Harhoff et al., 1999; Lemley and Shapiro, 2005; Gambardella et 
al., 2008) of specific inventions. Another interesting characteristic stems from the fact that 
the distribution of FCs is highly skewed with a large share of patents receiving no citations 
and a small minority of patents with a large number of FCs (Arts et al., 2013). Linking this 
skewedness to the value of an invention allows us to argue that outliers in the distribution of 
FCs pertain to more important inventions (Arts et al., 2013), with breakthrough patents 
falling in the top 1% or 5% in terms of FCs (Ahuja and Lampert, 2001; Singh and Fleming, 
2010). 
3.4 Model 
We run a series of logistic regression models (Hosmer et al., 2013) in order to assess the 
likelihood of being highly cited (through the number of FCs at 1, 2, and 5 Standard 
Deviations).  
Pr (Y=1|X1, …, X8) = β0 + β1*H’NPRs + β2*H’PRs_class + β3*H’PRs_subclass + βk*Controls 
with k=4, …,8. Table 3 shows a summary of the variables used into the model. 
TABLE 3 HERE 
Table 3. Variables for logistic regression models 
 
Figure 3 summarizes the method and data collection process: 
FIGURE 3 HERE 
Figure 3. Flowchart to summarize method and data collection process 
 
4. Results 
4.1 Descriptive Statistics 
In terms of correlations (see Appendix 4), we may notice that diversity at the level of NPRs 
has a negative correlation with all the levels of impact we are going to use. Even though the 
coefficients are not that large, they are still highly significant. NPRs diversity’s effect is 
lower for impactful innovations at the average level of FCs (-.018, p<.05), reinforces for 
those at 1SD (-.076, p<.001) and 2SD (-.073, p<.001), lowering again for extreme cases at 
5SD (-.054, p<.001). Instead, a positive and significant correlation emerges for PRs 
regardless the fact their diversity is at the level of technological classes or subclasses. 
However, higher coefficients emerge when it comes to consider the correlation between the 
diversity at the level of subclasses and the different levels of impact (e.g., .206, p<.001 for 
0SD cases; or .116, p<.001 for 2SD cases). This is supposedly due to the hierarchical 
structure of the IPC classification (Eisinger et al., 2013). As a consequence, the measure of 
diversity at one level does not take into account diversification at the underlying levels. This 
difference may also be reflected in the opposite and significant correlations between NPRs 
and PRs diversity (both at the level of classes and subclasses). Overall, all the variables 
pertaining to the scientific knowledge bases seem to run against the odds to generate 
impactful innovations in the Bioinformatics industry; the opposite holds for the 
technological knowledge bases.  
4.2 Gaining impact by recombining science and technology? 
In Table 4 we compare different logistic regression models, according to the definition of 
impact. The regression model with the interaction effects shows that the interplay of NPRs 
diversity and PRs diversity comes along with a small (but significant) decrease in the odds 
of generating impactful inventions. Such decreases become not significant as soon as 
extreme events are taken into account: for events falling in the 5SD of the FCs distribution, 
it seems that the interplay of scientific and technological knowledge bases does not play a 
significant role. On one side, recombining diverse knowledge bases at the level of NPRs and 
PRs technological subclasses has a negative impact only on the cases at 0SD and 1SD. On 
the other side, the negative effect of recombining NPRs knowledge bases and PRs 
technological classes expands until cases at 2SD. 
NPRs diversity shows three patterns. First, it has a positive coefficient when cases at the 
average level of SD are considered. Second, for cases at 2SD it decreases the odds of getting 
impactful inventions and in a significant way as soon as there is no interplay with PRs 
diversities. Third, and regardless the presence of interaction effects, it is still negative but 
not significant for more extreme cases namely, 2SD and 5SD. 
 
TABLE 4 HERE 
Table 4. Logistic regression model results (coefficients reported) 
 
PRs diversity shows a constant pattern: it has positive, always significant, and reinforcing 
coefficients at both the level of classes and subclasses. However, PRs diversity at the level 
of technological subclasses exhibits higher coefficients only for impact at the average level. 
Always higher coefficients for PRs diversity at the level of technological classes can be 
observed for increasingly extreme cases.  
By assessing the interaction effects between the main predictors, different optimal strategies 
may be identified (see Table 5).  
TABLE 5 HERE 
Table 5. Interaction effects assessment 
 The overall effect of NPRs diversity on the odds of generating impactful inventions in the 
Bioinformatics industry is positive when it comes to consider events at the average level of 
FCs (0SD); it ranges from -4.4% to +12.6%. The maximum level of increase (+12.6%) 
occurs when there is no interaction effect with the two PRs diversity indicators. The lower 
level instead occurs either when NPRs diverse knowledge bases are recombined with PRs 
diverse technological classes (-4.4%). Another interesting emerging aspect - which also 
reflects the results of the regression models - is that moving away from cases at the average 
level of FCs (0SD) implies that the overall effect of NPRs diversity is either negative or not 
significant. Furthermore, and although the magnitude is not so high (from -4.4% to -1.4%), 
recombination while shifting towards more extreme cases does not help in gaining impact. 
For extreme cases (1SD, 2SD, and 5SD), the overall effect of NPRs diversity is not 
significant. 
PRs diversity at the level of technological subclasses has a positive effect on the odds of 
generating impactful inventions with a magnitude ranging from +4.4% to +10.7%. For cases 
at 0SD and 1SD the PRs diversity at the level of subclasses allows for higher increase in the 
odds of generating impactful inventions (+8.7% and +5.9%). The interaction effect with 
NPRs diversity is still a good option (+8.7% and +4.4%). Instead, for more extreme cases 
(at 2SD and 5SD), either by recombining with diverse NPRs or not, there is a positive and 
significant increase in the odds (from +8.9% to 10.7%). An increase in the odds is allowed 
as soon as inventors decide to leverage on the diversity of PRs’ technological subclasses.  
PRs diversity at the level of technological classes has overall positive influence on the odds 
with a magnitude ranging from +5.9% to 18.3%. This predictor shows better performance 
when there is no interaction effect with NPRs diversity, and that happens when there is no 
recombination of technological and scientific knowledge bases. For increasingly extreme 
events (at 2SD and 5SD), the values are higher ranging from +8.5% to 18.3%. 
5. Discussion and Implications 
In this paper, we examined whether – and to what extent – scientific diversity and 
technological diversity contributed to the rise and development of the Bioinformatics 
industry. We analyzed the Bioinformatics patented inventions (USPTO) in the period 1976-
2014 and carried out a systematic assessment of their prior art (NPRs and PRs). By 
identifying scientific knowledge bases with NPRs and technological knowledge bases with 
PRs, we calculated their diversity by means of an entropy-based indicator namely, the 
Shannon-Wiener diversity index. We then performed logistic regressions in order to assess 
whether the diversity of NPRs and PRs might be considered good predictors of inventions’ 
impact. This analysis was done by considering different degrees of impact taking into 
account the characteristics of the FCs distribution. 
From the amount of both NPRs and PRs, and by looking at historical evidence of the 
development of the Bioinformatics industry, we preliminary argued that both science and 
technology play a role. In terms of quantity, the number of cited NPRs more than doubles 
the number of PRs. However, their contribution is somewhat different. Indeed, when we dug 
into the types of NPRs, we noticed the contribution of both SCI-covered references (e.g., 
indexed academic journals) and their non-scientific counterparts (e.g., books, patent related 
documents, and database accessions) were relevant. Also, the fact that most of SCI-covered 
sources are not Bioinformatics journals provided preliminary signs that diversity may matter. 
A similar trait emerges when we look at the technological classes and subclasses of PRs. 
Overall, in terms of quantity, Bioinformatics patents lay on a higher number of NPRs than 
PRs. 
When it comes to consider their diversity, descriptive statistics showed a negative correlation 
between NPRs diversity and all the levels of impact considered. On the contrary, and 
although with slightly different coefficients, PRs diversity is positively correlated with all 
the impact measures we used. Overall, diversity (or quality) of cited NPRs does not seem to 
be as important as quantity to the development of important inventions in the Bioinformatics 
industry. 
In our logistic regression models, a more nuanced picture emerged. First, by considering the 
models without interaction effects, NPRs diversity has a positive and significant effect on 
the odds of generating inventions at the average level of FCs; then, its effect becomes 
negative and highly significant concerning the inventions at 1SD of FCs giving inventors a 
decrease in the odds which amounts to -19.9%; finally, for extreme cases (2SD and 5SD in 
the FCs distribution), the coefficient is no longer significant. The coefficient concerning the 
PRs diversity at the level of technological classes and subclasses exhibited a positive sign 
and significantly contribute to increase the odds of generating impactful inventions. PRs 
diversity matters especially when dealing with extreme cases (at 5SD). But to escape the 
average impacts, inventors should leverage on PRs diversity at the level of technological 
classes in that an 18.3% increase in the odds can be reached out. 
Second, by considering the logistic regression models with the interaction effects between 
NPRs diversity and PRs diversity, results indicated another interesting aspect. The interplay 
of scientific and technological knowledge has almost always a negative coefficient, although 
its significance shades as soon as extreme cases are considered. Recombining science and 
technology does not seem to be the best option to increase the odds to gain impactful 
inventions in the Bioinformatics industry.   
This research moves a step further in the understanding the determinants of GPTs. Analyses 
of the patenting activity of the Bioinformatics industry, although valuable, only provide with 
evidence about the main technological classes of patents. To the best of our knowledge, we 
for the first time open the black-box of the Bioinformatics patents in order to shed light on 
the quantity and diversity (or quality) of the cited NPRs and PRs. Understanding how the 
latter are recombined is of fundamental importance in that insights are needed to disentangle 
the emergence and development of GPTs.  
Our findings contribute and extend the existing empirical and theoretical debate on 
knowledge recombination (Carnabuci and Operti, 2013; Gruber et al., 2013; Blackwell et 
al., 2009; Fleming and Sorenson, 2004), especially when it claims the higher the 
recombination of knowledge from areas distant to the one where someone is innovating, the 
higher the chances of generating important innovations. However, we highlight that only 
recombination occurring within scientific domains or technological domains can be 
considered, as their interplay may be detrimental to gain impactful inventions. Also, our 
contribution shows that the different degrees of impact require different degrees and types 
of knowledge recombination either within scientific domains or technological ones. NPRs 
diversity is more relevant for those inventions having a low impact; on the contrary, PRs 
diversity has impact for cases having moderate to extreme impact.  
Our findings also have important practical and policy implications. First, inventors in GPTs 
have to wisely recombine existing and diverse scientific/technological knowledge bases in 
order to increase the chances to generate impactful inventions. Within the boundaries of the 
considered industry (Bioinformatics) we can claim that it is better for inventors to rely either 
on diverse scientific knowledge bases or diverse technological knowledge bases. Their 
interaction does not represent the best recipe. Second, inventors (and the organizations they 
belong to) may reinterpret our findings in the light of the framework Murmann and Frenken 
(2006) advanced, perhaps locating Bioinformatics inventions in the radical-square 
innovation quadrant: a large scope of new knowledge mainly residing in PRs diverse sources 
increases the odds of getting high performance improvements. Third, as recombination of 
diverse PRs seems to be the strongest mechanism to gain impact, by leveraging on it 
inventors in the Bioinformatics industry could make the transition from technological 
trajectories to new paradigms potentially more concreate (Dosi, 1982). Policy makers may 
find interesting the fact that understanding what is behind the scene of GPTs, they can 
foresee better ways to prioritize investments for assuring a long-term economic growth. 
Also, they may find ways to further stimulate collaborative efforts between the 
heterogeneous actors to enact network dynamics, enabling them to better recombine their 
knowledge bases. Finally, by opening the black box of the NPRs and PRs, policy makers 
can start posing the basis for a more univocal way to identify Bioinformatics patents in the 
different patent classification systems.   
6. Limitations and Future Research 
This research does not come without limitations. First and foremost, we relied on USPTO 
patents only. Future research may extend their analyses by including European patents as 
well in order to assess whether some difference exist in both the PRs and NPRs citations 
patterns. Second, we do not dig into the content of the cited prior art; in this vein, future 
studies may investigate the semantic content of prior also by looking at their evolution. 
Therefore, new content-based indicators signaling impact of Bioinformatics inventions can 
be generated and tested. Third, our focus is on a peculiar case of GPT which may not allow 
for generalizing our results. Future researchers may further elaborate on this topic by 
comparing other GPTs and questioning or supporting our findings. Fourth, we do not dig 
into the inventor’s characteristics; this aspect may be useful to understand who the most 
prominent scientists in the Bioinformatics field are, who among them is able to play the 
ambidextrous role of producer of scientific and technological outcomes, or how their 
curricula look like. This may provide future readers with a complete picture of the necessary 
skills to survive complex industries like Bioinformatics. Fifth, studying the impact generated 
by networks of inventors and whether these networks are characterized by strong industry-
university links is worthy of further investigation. Finally, analyzing how – and to what 
extent – the impact of bioinformatics patents varies across industrial boundaries (Messeni 
Petruzzelli et al., 2015) represents an interesting research avenue. 
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